Apply to become a board member by sending your resume to info@journivision.com

Oncology & Therapy Vision

Aims & Scope

Oncology & Therapy Vision (OTV) is a global open-access journal dedicated to advancing cancer research and treatment. It provides a trusted platform for clinicians, researchers, academics, and healthcare professionals to publish high-quality work on cancer biology, diagnosis, therapy, and patient-centered care. The journal promotes collaboration across disciplines to connect fundamental research with clinical practice. It emphasizes ethical research practices, strong scientific standards, and international cooperation to support cancer prevention, improve treatment outcomes, and enhance healthcare worldwide.

Aims:

The primary goal of Oncology & Therapy Vision is to:

  • Promote high-quality research in oncology and therapeutic sciences
  • Foster innovation in cancer diagnosis, treatment options, and disease management
  • Support translating laboratory discoveries into clinical practice
  • Encourage multidisciplinary and evidence-based approaches to oncology care
  • Offer a global platform for sharing scientific advancements in cancer research
Scope:

The journal publishes original research articles, review papers, systematic reviews, meta-analyses, case reports, short communications, and clinical investigations in, but not limited to, the following areas:

  • Medical Oncology
  • Surgical Oncology
  • Radiation Oncology
  • Hematologic Malignancies
  • Cancer Biology and Molecular Oncology
  • Cancer Genetics and Genomics
  • Immuno-oncology and Targeted Therapies
  • Chemotherapy and Pharmacological Treatments
  • Precision and Personalized Oncology
  • Cancer Detection and Biomarker Research
  • Translational and Clinical Oncology
  • Palliative and Supportive Oncology
  • Oncology Nursing and Patient Management
  • Pediatric and Geriatric Oncology
  • Cancer Prevention and Epidemiology
  • Integrative and Complementary Oncology
  • Clinical Trials and Evidence-Based Cancer Care
What's App : +1 347 428 8392